Asia
BioSpace sat down with 12 executives who shared their thoughts on the coming year and decade.
Biopharma and life sciences companies and organizations provide updates on their businesses and pipelines.
The novelty of this technique lies in the capture of an intermediate state during the conversion of glial cells into neurons.
Low-income countries still struggle to get first jabs into arms. Researchers and pharma companies continue to push for low-cost vaccines and drugs worldwide.
Positive data from a Phase II/III trial of Bharat Biotech vaccine, Covaxin. Read more about the research and know about the efficiency of the vaccine.
Korea Economic Daily, published a story saying that Samsung Group was in talks to acquire Biogen. However, Samsung BioLogics stated in a regulatory filing yesterday that the rumor is not true.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Novartis announced it has licensed BeiGene’s ociperlimab, a late-stage TIGIT inhibitor, to bolster its immunotherapy pipeline.
The year kicked off with a bang as multiple companies raced to a public listing.
PRESS RELEASES